Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

There was no significant difference in sNfL levels at baseline between UVB‐PT and non‐UVB‐PT CIS groups (20.7 and 20.1 pg/ml, respectively; p = .494), or correlations with age, EDSS score, or serum 25(OH)D levels.

Source: Serum NfL levels. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The reasons for missing sample collection included withdrawal from the blood collection part of the study due to anxiety (n = 4 samples missed), when participants were not able to attend appointments (n = 7 samples missed), and relocation to another state following completion of phototherapy (n = 2 samples missed).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Changes in serum neurofilament light chain levels following narrowband ultraviolet B phototherapy in clinically isolated syndrome

Study design awaiting verification · Brain and Behavior · 2022

Original publication title

Changes in serum neurofilament light chain levels following narrowband ultraviolet B phototherapy in clinically isolated syndrome

Marzena J. Fabis‐Pedrini; Jens Kuhle; Katherine M. A. Roberts; Stephanie Trend; Anderson P. Jones; Aleksandra Maceski; William M. Carroll; Robyn M. Lucas; Frank L. Mastaglia; Prue H. Hart; Allan G. Kermode

© 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our findings provide the basis for further studies to determine the utility of sNfL levels as a marker of neuro‐axonal damage in CIS and early MS and for assessing the efficacy of new therapeutic interventions such as UVB‐PT.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To determine whether serum neurofilament light chain (sNfL) levels are suppressed in patients with the clinically isolated syndrome (CIS) following narrowband ultraviolet B phototherapy (UVB‐PT).

Source: Objective

Abstract: What methods does the paper describe?

sNfL levels were measured using a sensitive single‐molecule array assay at baseline and up to 12 months in 17 patients with CIS, 10 of whom received UVB‐PT, and were compared with healthy control (HC) and early relapsing remitting multiple sclerosis (RRMS) group. sNfL levels were correlated with magnetic resonance imaging total lesion volume (LV) determined using icobrain version 4.4.1 and with clinical outcomes.

Source: Methods

Abstract: Results

Baseline median sNfL levels were significantly higher in the CIS (20.6 pg/mL, interquartile range [IQR] 13.7 to 161.4) and RRMS groups (36.6 pg/ml [IQR] 16.2 to 212.2) than in HC (10.7 pg/ml [IQR] 4.9 to 21.5) (p = .012 and p = .0002, respectively), and were strongly correlated with T2 and T1 LV at 12 months (r = .800; p = .014 and r = .833; p = .008, respectively) in the CIS group. Analysis of changes in sNfL levels over time in the CIS group showed a significant cumulative suppressive effect of UVB‐PT in the first 3 months (UVB‐PT −10.6% vs non‐UVB‐PT +58.3%; p = .04) following which the levels in the two groups converged and continued to fall.

Source: Results

Abstract: Conclusions

Our findings provide the basis for further studies to determine the utility of sNfL levels as a marker of neuro‐axonal damage in CIS and early MS and for assessing the efficacy of new therapeutic interventions such as UVB‐PT.

Source: Conclusions
Authors’ abstract

Abstract

Objective

To determine whether serum neurofilament light chain (sNfL) levels are suppressed in patients with the clinically isolated syndrome (CIS) following narrowband ultraviolet B phototherapy (UVB‐PT).

Methods

sNfL levels were measured using a sensitive single‐molecule array assay at baseline and up to 12 months in 17 patients with CIS, 10 of whom received UVB‐PT, and were compared with healthy control (HC) and early relapsing remitting multiple sclerosis (RRMS) group. sNfL levels were correlated with magnetic resonance imaging total lesion volume (LV) determined using icobrain version 4.4.1 and with clinical outcomes.

Results

Baseline median sNfL levels were significantly higher in the CIS (20.6 pg/mL, interquartile range [IQR] 13.7 to 161.4) and RRMS groups (36.6 pg/ml [IQR] 16.2 to 212.2) than in HC (10.7 pg/ml [IQR] 4.9 to 21.5) (p = .012 and p = .0002, respectively), and were strongly correlated with T2 and T1 LV at 12 months (r = .800; p = .014 and r = .833; p = .008, respectively) in the CIS group. Analysis of changes in sNfL levels over time in the CIS group showed a significant cumulative suppressive effect of UVB‐PT in the first 3 months (UVB‐PT −10.6% vs non‐UVB‐PT +58.3%; p = .04) following which the levels in the two groups converged and continued to fall.

Conclusions

Our findings provide the basis for further studies to determine the utility of sNfL levels as a marker of neuro‐axonal damage in CIS and early MS and for assessing the efficacy of new therapeutic interventions such as UVB‐PT.

Serum neurofilament light chain (sNfL) levels were measured using a sensitive single‐molecule array assay at baseline and up to 12 months in 17 patients with the clinically isolated syndrome (CIS), 10 of whom received UVB‐phototherapy and seven did not receive UVB‐phototherapy. Longitudinal comparisons of sNfL levels in the UVB‐phototherapy treated versus non‐UVB‐phototherapy CIS participants using a mixed‐effects model showed that over the first 3 months there was a significant cumulative suppressive effect of UVB‐phototherapy.

Publication and source details

Original title: Changes in serum neurofilament light chain levels following narrowband ultraviolet B phototherapy in clinically isolated syndrome

Marzena J. Fabis‐Pedrini; Jens Kuhle; Katherine M. A. Roberts; Stephanie Trend; Anderson P. Jones; Aleksandra Maceski; William M. Carroll; Robyn M. Lucas; Frank L. Mastaglia; Prue H. Hart; Allan G. Kermode

Brain and Behavior · 2022

* Correspondence
Professor Allan G. Kermode, Perron Institute for Neurological and Translational Science, The University of Western Australia, 8 Verdun Street, Nedlands, WA 6009, Australia.
Email: kermode@me.com
© 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLChttps://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Multiple Sclerosis Research Australia 10.13039/50110000092418‐0376Multiple Sclerosis Western AustraliaNational Health and Medical Research Council of AustraliaID 1067209

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T10:18:49.252831+00:00

DOI: 10.1002/brb3.2494 · PMC8865160